PATENT CLAIM ANALYSIS

Application Number: 15951848
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "056000"]

Abstract:
The present invention relates to the use of heparin derivatives for the prevention and/or treatment of cancer and/or cancer metastasis. The heparin derivatives are substantially 2-O and/or 6-O desulphated heparins which function as inhibitors of galectin-3 activity.

Claim (Index 30):
A method according to  claim 16 , wherein the cancer is selected from the group consisting of colorectal cancer, head and neck cancer, pancreatic cancer, breast cancer, lung cancer, melanoma, thyroid cancer, and bladder cancer.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 91.0
- Lexical Diversity: 1.34483
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14440005', '11882978', '11314736', '12227630', '13304292']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8180085342619248
- 35 USC 102 Novelty (BERT): 0.528499997375548
- Combined Prediction Score: 0.7890576805732871
- Mean Citation Score: 281.08527999999995
- Max Citation Score: 341.1478600000001
- Similarity Product: 192.3365733071936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test